Close Menu

Principal/ Staff Chemist

Job Location
7026 Koll Center Parkway
Pleasanton, CA 94566
United States

Inscripta offers a competitive base salary, bonus plan, benefits package and stock options to all team members.  Join us and work with a great team of people developing the world's first scalable platform for benchtop Digital Genome Engineering. Inscripta is headquartered in Boulder, CO with offices in Pleasanton and San Diego, CA.  This position can belocated in either our Boulder, CO OR Pleasanton, CA office.

Job Description

Inscripta is developing the world's first scalable platform for benchtop Digital Genome Engineering. The company’s advanced CRISPR-based platform, consisting of an instrument, reagents, and software, will offer a fully automated workflow that enables multiplexed, trackable editing of cells at an unprecedented scale. Inscripta’s goal is to empower scientists whose gene editing research is stifled by current technical and licensing limitations. By providing this unique platform and engaging in collaborative business practices, such as making its MAD7 CRISPR nuclease free for research purposes, the company enables scientists to realize a new era of biological discovery.   Due to rapid growth, Inscripta is seeking a Chemist to develop the next generation DNA editing tools. This position will be located in our Boulder, CO or Pleasanton, CA office.

We are looking for an outstanding Staff Scientist/Principal Scientist/Lead Chemist to drive development of a CRISPR-based DNA editing platform.  This individual will innovate in areas of chemistry development, process optimization, hardware/consumable development, and product automation. Essential aspects of this position include: project leadership, innovative solutions, and formulation design, synthesis, and analysis.  The right candidate will leverage their creativity and research experience to build an industry-leading genetic-engineering platform in a highly innovative, team-oriented, fast-paced R&D environment.


• Provide scientific leadership in a technical team to build a high-throughput automated, genetic-engineering platform

• Design and synthesize new polymers, materials, and chemistries for use in microfluidics and nucleic acid applications

• Perform bioconjugation, purification, and characterization of oligonucleotide complexes

• Present clear and concise written and oral communications to colleagues and supervisors


• Demonstrated experience solving challenging, interdisciplinary research/development problems at the interface of chemistry, nanotechnology, biology, materials, and engineering

• Expert knowledge of chemistry techniques used for nucleic acid manipulation, functionalization, and fluidic device surface modifications

• Demonstrated expertise in the development of new materials such as nano-materials and nanotechnology, composites, and/or novel polymeric materials

• Experience in oligonucleotide or peptide synthesis, modification, and purification is a plus

• Desire to work in a team environment and collaborate closely with other cross-functional and geographically distributed teams

• Ph.D. in materials science, polymer, organic, biochemical or related field.  A minimum of 5 yrs experience in a multidisciplinary R&D setting.   

About Our Organization

Inscripta is a gene editing technology company dedicated to creating the tools needed to revolutionize how we feed, fuel, and heal humanity. This includes developing a family of CRISPR enzymes (called MADzymes), bespoke nucleases for researchers and commercial partners, and a full suite of gene editing tools (software, instruments, and reagents) that will significantly increase the speed and efficiency of precision gene editing.

A proposed rule would deem graduate students at private institutions to not be employees, which ScienceInsider reports might affect unionization efforts.

A new study finds that a positive lab environment can encourage undergraduates to continue to perform research.

A new analysis suggests non-US citizen STEM PhDs might pass up jobs at US-based startups due to visa concerns.

A UK survey of researchers who identified as LGBT+ and allies uncovered evidence of unwelcoming workplace climates in the physical sciences.